An experienced clinician-researcher, Prof Ashkenazi has guided multiple vaccines through clinical and regulatory approval phases to market.
Ness Ziona, Israel – September 7, 2016 – BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV, TASE: BVXV), a clinical stage biopharmaceutical company focused on developing and commercializing a vaccine against current and future seasonal and pandemic influenza strains, is pleased to announce the appointment of Professor Shai Ashkenazi to its Scientific Advisory Board (SAB).
Ashkenazi is a clinical and regulatory vaccine expert, with significant contributions to flu and other infectious disease vaccine research and development. He has served on the clinical trial advisory boards for the development of a pediatric flu vaccine, vaccines for enteric infections, as well as other infectious diseases.
Ashkenazi has a deep understanding and experience with BiondVax’s universal flu vaccine as he served as the head of the data and safety monitoring board (DSMB) in all of the company’s clinical trials in Israel and abroad.
Professor Ashkenazi commented, “I am excited to join BiondVax’s SAB and to be part of the efforts to bring better protection against the flu in order to save lives.”
The head of BiondVax’s Scientific Advisory Board, Professor Ruth Arnon stated, “We’re honored Prof. Ashkenazi has joined the team. His breadth of experience in marshalling pharma products through clinical trials, regulatory and marketing approval will be of great value as BiondVax begins to progress towards Phase 3 trials. Our team – the SAB, board, and employees – are well positioned to achieve approval for M-001 as the first universal flu vaccine.”
Our team – the SAB, board, and employees – are well positioned to achieve approval for M-001 as the first universal flu vaccine
Among other positions, Ashkenazi currently holds the Lea and Arieh Pickel Chair for Pediatric Research at the Sackler Faculty of Medicine, Tel Aviv University. He is also Chair of the Department of Pediatrics A at Schneider Children’s Medical Center and Head of the Research Laboratory for Pediatric Infectious Diseases at the Felsenstein Medical Research Center.
Ashkenazi is an editorial board member of several international medical journals, has served on numerous national and international committees, authored over 200 medical publications and is editor of the Israeli Textbook of Pediatrics.